Early research (Phase 1)Ended earlyNCT02454270
What this trial is testing
A Dose Escalation Study of Duvortuxizumab in Participants With Relapsed or Refractory B-cell Malignancies
Who this might be right for
Leukemia, Lymphocytic, Chronic, B-CellLymphoma, Large B-Cell, DiffuseLymphoma, Follicular+2 more
Janssen Research & Development, LLC 59